Abstract
The findings of a comparative study of the therapeutic efficacy of various psychosis treatment strategies in the users of synthetic cannabinoids (SC) suggest that antipsychotic drugs in the complex therapy of psychosis increase the treatment efficacy, improves the patients' adherence to treatment, and increases the likelihood that the patients will cease SC use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Cannabis Use, Neurobiology, Psychology, and Treatment
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
